secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2021-09-09T23:59:59+00:00
Accession:  0001193125-21-268317
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Gemini Therapeutics CTO Scott Lauder resigns effective September 17, 2021
-------------------------------------------------------------------------

- Dr. Scott Lauder, Ph.D., notified Gemini Therapeutics of his resignation as Chief Technology Officer on Sept 7, 2021.
- Resignation effective September 17, 2021; no replacement announced.
- Company states departure is not due to any disagreement with the Company or Board.
- Company thanks Dr. Lauder for his years of service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000119312521268317/0001193125-21-268317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000119312521268317/d213539d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-268317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer